Oral oncology

publication venue for

The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders.. 168. 2025
Re-evaluating Lymph Node Yield, Lymph Node Ratio, and the number of metastatic nodes as prognostic factors in oral cavity squamous cell carcinoma.. 166. 2025
MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.. 151. 2024
Young non-smokers with oral cancer: What are we missing and why?. 127. 2022
Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs.. 122. 2021
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.. 110. 2020
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.. 104. 2020
Neck management in patients with olfactory neuroblastoma.. 101. 2019
MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma.. 98. 2019
APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.. 96. 2019
Polymorphous adenocarcinoma of salivary glands.. 95. 2019
Sex disparities in salivary malignancies: Does female sex impact oncological outcome?. 94. 2019
Survival outcomes after treatment of cancer of the oral cavity (1985-2015).. 90. 2019
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes.. 90. 2019
Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution.. 83. 2018
Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution.. 78. 2018
Complications following transoral robotic surgery (TORS): A detailed institutional review of complications.. 67. 2017
A clinicopathologic study on SS18 fusion positive head and neck synovial sarcomas.. 66. 2017
The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.. 64. 2016
Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.. 62. 2016
A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.. 61. 2016
Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma.. 56. 2016
Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.. 51. 2015
Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience.. 51. 2015
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer.. 51. 2015
Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC).. 50. 2014
Patients with low lying lymph nodes are at high risk for distant metastasis in oropharyngeal cancer.. 50. 2014
The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scan.. 50. 2014
A novel tumor: specimen index for assessing adequacy of resection in early stage oral tongue cancer.. 50. 2013
Outcomes of a head and neck cancer screening clinic.. 49. 2013
Carcinoma of the oral tongue in patients younger than 30 years: comparison with patients older than 60 years.. 49. 2013
Risk stratification in medullary thyroid cancer: moving beyond static anatomic staging.. 49. 2013
Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.. 48. 2012
Outcomes of oral cavity squamous cell carcinoma in pediatric patients.. 46. 2010
Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells.. 40. 2004
Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer.. 39. 2003
Mouthwash use and dentures in relation to oral epithelial dysplasia.. 33. 1997
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.. 126. 2022
Are our patients doing better? A single institution experience of an evolving management paradigm for sinonasal mucosal melanoma.. 112. 2020
Squamous cell carcinoma associated with chronic graft versus host disease-like/lichen planus-like lesion of the oral cavity in a patient managed for metastatic melanoma with a PD-1 inhibitor pembrolizumab.. 63. 2016
Clinical and molecular heterogeneity of head and neck spindle cell and sclerosing rhabdomyosarcoma.. 58. 2016
Radiographic osteoradionecrosis of the jaw with intact mucosa: Proposal of clinical guidelines for early identification of this condition.. 51. 2015
Osteonecrosis of the jaw a new complication related to Ipilimumab.. 51. 2015
Adjuvant treatment for head and neck cancer in solid organ transplant recipients.. 51. 2015
Paradigm shifts in staging of thyroid cancer.. 72. 2017
Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma.. 62. 2016
Unmet needs for patients with salivary gland cancer.. 60. 2016
Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer. 2025
The head and neck cancer genome in the era of immunotherapy. 2020
Elective neck dissection in oral squamous cell carcinoma: Past, present and future. 2019
Extrathyroidal extension-what does it mean. 2017
In vivo confocal microscopy for the oral cavity: Current state of the field and future potential. 2016
Thyroid cancer: surgery for the primary tumor. 2013
Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision making. 2013
Anaplastic thyroid cancer. 2013
Management of regional nodes in thyroid cancer. 2013
Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. 2012
Distant metastases from head and neck squamous cell carcinoma. Part II. Diagnosis. 2012
Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment. 2012
Large cell neuroendocrine carcinoma of the head and neck. 2011
Tumours of familial origin in the head and neck. 2006
Management of the N0 neck--reference or preference. 2005
Elective and therapeutic selective neck dissection. 2005
Management of mandibular invasion: when is a marginal mandibulectomy appropriate? 2005
Paragangliomas of the head and neck. 2004
Management of malignant sublingual salivary gland tumors. 2004
Management of cancer of the retromolar trigone. 2003
Changing concepts in the surgical management of the cervical node metastasis. 2003
Current management of tonsillar cancer. 2003
Sentinel lymph node biopsy in head and neck cancer. 2003
Current philosophy on the management of cancer of the base of the tongue. 2003
Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. 2002

VIVO Weill Cornell Medical College

Oral oncology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)